Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acthar
Pharma
Mallinckrodt, Endo become Keenova following generics spinoff
Some three months after merging, Mallinckrodt and Endo have successfully spun off their combined sterile injectables and generics businesses.
Fraiser Kansteiner
Nov 11, 2025 9:54am
Mallinckrodt, facing $1.9B in settlements, files for bankruptcy
Oct 12, 2020 10:52am
Mallinckrodt could owe $650M in back Acthar rebates
Mar 16, 2020 9:52am
Mallinckrodt faces federal prosecutors in Acthar rebate lawsuit
Mar 3, 2020 4:25pm
Mallinckrodt unloads its CDMO for $250M as potential liabilities mount
Sep 10, 2019 10:34am
Mallinckrodt investors jump ship as bankruptcy talk mounts
Sep 5, 2019 9:26am
